Synthesis of chalcone derivatives as potential anti-diabetic agents. 2012

Chi-Ting Hsieh, and Tusty-Jiuan Hsieh, and Mohamed El-Shazly, and Da-Wei Chuang, and Yi-Hong Tsai, and Chiao-Ting Yen, and Shou-Fang Wu, and Yang-Chang Wu, and Fang-Rong Chang
Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 807, Taiwan.

Chalcones bearing electron donating or electron withdrawing substitutions were prepared and their glucose uptake activity was evaluated. Chalcone derivatives were synthesized in one step protocol with high purity and yield. Chalcones with chloro, bromo, iodo and hydroxy substitutions at position 2 on A-ring exhibited the highest activity with glucose medium concentration (210 to 236 mg/dl) compared to pioglitazone and rosiglitazone (230 and 263 mg/dl, respectively). Also chalcones with iodo substitution at position 3 on A-ring were comparably active (≤238 mg/dl). The structure-activity relationship of the tested chalcones was studied and the findings were supported statistically.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077154 Rosiglitazone A thiazolidinedione that functions as a selective agonist for PPAR GAMMA. It improves INSULIN SENSITIVITY in adipose tissue, skeletal muscle, and the liver of patients with TYPE 2 DIABETES MELLITUS. 5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate,Avandia,BRL 49653,BRL-49653,BRL49653,Rosiglitazone Maleate
D000077205 Pioglitazone A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS. Pioglitazone Hydrochloride,5-(4-(2-(5-Ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione,AD 4833,AD-4833,Actos,U 72107A,U-72107A,U72,107A,AD4833,U72107A
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001693 Biological Transport, Active The movement of materials across cell membranes and epithelial layers against an electrochemical gradient, requiring the expenditure of metabolic energy. Active Transport,Uphill Transport,Active Biological Transport,Biologic Transport, Active,Transport, Active Biological,Active Biologic Transport,Transport, Active,Transport, Active Biologic,Transport, Uphill
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017667 Adipocytes Cells in the body that store FATS, usually in the form of TRIGLYCERIDES. WHITE ADIPOCYTES are the predominant type and found mostly in the abdominal cavity and subcutaneous tissue. BROWN ADIPOCYTES are thermogenic cells that can be found in newborns of some species and hibernating mammals. Fat Cells,Lipocytes,Adipocyte,Cell, Fat,Cells, Fat,Fat Cell,Lipocyte

Related Publications

Chi-Ting Hsieh, and Tusty-Jiuan Hsieh, and Mohamed El-Shazly, and Da-Wei Chuang, and Yi-Hong Tsai, and Chiao-Ting Yen, and Shou-Fang Wu, and Yang-Chang Wu, and Fang-Rong Chang
January 2015, Journal of advanced pharmaceutical technology & research,
Chi-Ting Hsieh, and Tusty-Jiuan Hsieh, and Mohamed El-Shazly, and Da-Wei Chuang, and Yi-Hong Tsai, and Chiao-Ting Yen, and Shou-Fang Wu, and Yang-Chang Wu, and Fang-Rong Chang
November 2018, Chemical biology & drug design,
Chi-Ting Hsieh, and Tusty-Jiuan Hsieh, and Mohamed El-Shazly, and Da-Wei Chuang, and Yi-Hong Tsai, and Chiao-Ting Yen, and Shou-Fang Wu, and Yang-Chang Wu, and Fang-Rong Chang
December 2019, Journal of enzyme inhibition and medicinal chemistry,
Chi-Ting Hsieh, and Tusty-Jiuan Hsieh, and Mohamed El-Shazly, and Da-Wei Chuang, and Yi-Hong Tsai, and Chiao-Ting Yen, and Shou-Fang Wu, and Yang-Chang Wu, and Fang-Rong Chang
August 2018, The Journal of antibiotics,
Chi-Ting Hsieh, and Tusty-Jiuan Hsieh, and Mohamed El-Shazly, and Da-Wei Chuang, and Yi-Hong Tsai, and Chiao-Ting Yen, and Shou-Fang Wu, and Yang-Chang Wu, and Fang-Rong Chang
August 2011, European journal of medicinal chemistry,
Chi-Ting Hsieh, and Tusty-Jiuan Hsieh, and Mohamed El-Shazly, and Da-Wei Chuang, and Yi-Hong Tsai, and Chiao-Ting Yen, and Shou-Fang Wu, and Yang-Chang Wu, and Fang-Rong Chang
September 2021, Bioorganic & medicinal chemistry letters,
Chi-Ting Hsieh, and Tusty-Jiuan Hsieh, and Mohamed El-Shazly, and Da-Wei Chuang, and Yi-Hong Tsai, and Chiao-Ting Yen, and Shou-Fang Wu, and Yang-Chang Wu, and Fang-Rong Chang
April 2022, European journal of medicinal chemistry,
Chi-Ting Hsieh, and Tusty-Jiuan Hsieh, and Mohamed El-Shazly, and Da-Wei Chuang, and Yi-Hong Tsai, and Chiao-Ting Yen, and Shou-Fang Wu, and Yang-Chang Wu, and Fang-Rong Chang
January 2023, Current drug discovery technologies,
Chi-Ting Hsieh, and Tusty-Jiuan Hsieh, and Mohamed El-Shazly, and Da-Wei Chuang, and Yi-Hong Tsai, and Chiao-Ting Yen, and Shou-Fang Wu, and Yang-Chang Wu, and Fang-Rong Chang
May 2012, Bioorganic & medicinal chemistry letters,
Chi-Ting Hsieh, and Tusty-Jiuan Hsieh, and Mohamed El-Shazly, and Da-Wei Chuang, and Yi-Hong Tsai, and Chiao-Ting Yen, and Shou-Fang Wu, and Yang-Chang Wu, and Fang-Rong Chang
February 2017, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society,
Copied contents to your clipboard!